Of patients who seek treatment for alcohol use disorder, 60% to 80% relapse within a year. Taking the medication naltrexone reduces this number by a third. Yet only 20% of patients receive medications because they do not work well for everyone. Medical University of South Carolina researchers report in Alcoholism: Clinical and Experimental Research that measuring variants in just three brain genes makes it is possible to predict who will benefit from naltrexone.
- Stigma impacts psychological, physical health of multiracial people
- Common treatment for diabetic macular edema not effective in Black individuals
- Do asymptomatic kids with COVID-19 carry less virus?
- Nasal septum surgery can affect behaviour, say medics from RUDN University
- FEFU scientists helped design a new type of ceramics for laser applications